We first utilized a mouse CT-26 xenograft model in a prevention-based scenario to assess the combined effects of MS-20 and an anti-PD1 antibody on the treatment of colon cancer (Figure S1a). This evidence concerns the gene PDCD1 and colonic neoplasm.